Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche’s 9 Months Sales 2019 Audio Webcast and Conference Call Donnerstag, 19. September 2019 - 10:06

?v=05292019124700

1b4f54aa-fe44-48d6-bf3a-a3ae8611b7d2

Invitation to Roche's 9 Months Sales 2019 Audio Webcast and Conference Call

Roche will publish its Sales Results for the 3rd Quarter of 2019 prior to the opening of the Swiss Stock Exchange on 
Wednesday, October 16th, 2019

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release
 will be e-mailed and posted on the Roche IR website >
 click here
Presentation slides will be posted on the Roche IR website > click here

We would like to invite all interested parties to dial in as outlined below:

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

Audio webcast and conference call
 will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer


Access to Audio webcast
Please access by clicking on > ir.roche.com

Access to Conference Call (pre-registration required)
You will receive phone numbers, webcast link, passcode and your personal PIN to direct access the Conference Call by pre-registering here.

Should you have any issues with the registration, please dial the following numbers on the day of the Conference Call & Webcast 10-15 minutes prior to conference start:

+41 (0) 58 310 50 00 (Europe & RoW) 

+44 (0) 207 107 0613 (UK)

+1 631 570 56 13 (USA)

A replay of the webcast will be available via > ir.roche.com

Best regards,

Karl Mahler
Head of Investor Relations

 

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: 
jon_kaspar.bayard@roche.com

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com

 

 

All rights reserved ©2019 F. Hoffmann-La Roche Ltd.
Investor Relations, Grenzacherstrasse 124, CH-4070 Basel, Switzerland